Chief of GI Surgical Oncology, University of Pittsburgh
General Surgery
Dr. Herbert J. Zeh III, MD
|
|
Give Review
Herbert J. Zeh III works in the field of General Surgery. He went to University of Pittsburgh School of Medicine. He received awards:"Fellow (FACS)". Herbert J. Zeh III is a published doctor. He has 91 papers published. The most current publication "Minimally Invasive Approaches to Pancreatic Surgery." He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Outcomes of CytoreDuctive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.
- A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts.
- The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.
- Assessment of Quality Outcomes for Robotic Pancreaticoduodenectomy: Identification of the Learning Curve.
- Nuclear DAMP complex-mediated RAGE-dependent macrophage cell death.
- Robotic surgery for benign duodenal Tumors.
- First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.
- Serum CA 19-9 response to neoadjuvant therapy is associated with outcome in pancreatic adenoCarcinoma.
- Institutional Learning Curve of CytoreDuctive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal Malignancies.
- DAMPs, ageing, and Cancer: The 'DAMP Hypothesis'
- Robotic total pancreatectomy with or without autologous islet cell transplantation: replication of an open technique through a minimal access approach.
- HMGB1 in health and Disease.
- HMGB1 Phenotypic Role Revealed with Stress.
- Does Obesity Affect Outcomes of CytoreDuctive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Disseminated Mucinous Appendiceal Neoplasms?
- Clinicopathologic and molecular Analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a thre...
- Loss of SMAD4 staining in pre-operative cell blocks is associated with distant metastases following pancreaticoduodenectomy with venous resection for pancreatic Cancer.
- Intracellular Hmgb1 Inhibits Inflammatory Nucleosome Release and Limits Acute Pancreatitis in Mice.
- Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome Analysis.
- Impact of Aggressive Histology and Location of Primary Tumor on the Efficacy of Surgical Therapy for Peritoneal Carcinomatosis of ColoRectal Origin.
- Integration of KRAS testing in the diagnosis of Pancreatic cystic lesions: a clinical experience of 618 Pancreatic cysts.
- Aggressive Locoregional Surgical Therapy for Gastric Peritoneal Carcinomatosis.
- 250 robotic Pancreatic resections: safety and feasibility.
- Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic Cancer.
- Acinar cell cystadenoma of the pancreas: a benign neoplasm or non-neoplastic ballooning of acinar and Ductal epithelium?
- HMGB1 in Cancer: Good, Bad, or Both?
- Phase II Study of InDuction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic ...
- Sweating the small stuff: microRNAs and genetic changes define pancreatic Cancer.
- Comparative effectiveness of minimally invasive and open distal pancreatectomy for Ductal adenocarcinoma.
- Abdominal compartment syndrome is an early, lethal complication of acute pancreatitis.
- Signet Ring Cell ColoRectal Carcinoma: A Distinct Subset of Mucin-poor Microsatellite-stable Signet Ring Cell Carcinoma Associated With Dismal Prognosis.
- Extensive cytoreDuctive surgery for appendiceal carcinomatosis: morbidity, mortality, and survival.
- Resection of isolated local and metastatic recurrence in periampullary adenoCarcinoma.
- A Phase I Trial of Isolated Hepatic Perfusion (IHP) Using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases from Colorectal Cancer.
- Aggressive locoRegional management of recurrent peritoneal sarcomatosis.
- The receptor for advanced glycation end proDucts promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.
- Significance of serum tumor marker levels in peritoneal Carcinomatosis of appendiceal origin.
- DAMPs and autophagy: Cellular adaptation to injury and unscheduled cell death.
- The HMGB1/RAGE inflammatory pathway promotes Pancreatic tumor growth by regulating mitochondrial bioenergetics.
- Robotic-Assisted Minimally Invasive Central Pancreatectomy: Technique and Outcomes.
- Robot-assisted minimally invasive distal pancreatectomy is superior to the laparoscopic technique.
- NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells.
- Damage Associated Molecular Pattern Molecule-Induced microRNAs (DAMPmiRs) in Human Peripheral Blood Mononuclear Cells.
- The current state of robotic-assisted Pancreatic surgery.
- Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenoCarcinoma following neoadjuvant therapy.
- Inhibiting Systemic Autophagy during Interleukin 2 Immunotherapy Promotes Long-term Tumor Regression.
- AGER/RAGE-mediated autophagy promotes Pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway.
- Mucin as a therapeutic target in pseudomyxoma peritonei.
- Direct molecular interactions between HMGB1 and TP53 in colorectal Cancer.
- Metabolic regulation by HMGB1-mediated autophagy and mitophagy.
- Outcomes After Robot-Assisted Pancreaticoduodenectomy for Periampullary Lesions.
- HMGB1 as an autophagy sensor in oxidative stress.
- Dendritic cells in Cancer immunotherapy: vaccines or autologous transplants?
- High-mobility group box 1 is essential for mitochondrial quality control.
- Technical Aspects of Robotic-Assisted Pancreaticoduodenectomy (RAPD).
- Erratum to: Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer.
- The Receptor for Advanced Glycation End-ProDucts (RAGE) Protects Pancreatic Tumor Cells Against Oxidative Injury.
- Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic Cancer.
- High-mobility group box 1, oxidative stress, and Disease.
- RAGE regulates autophagy and apoptosis following oxidative injury.
- High mobility group box 1 (HMGB1) Activates an Autophagic Response to Oxidative Stress.
- Robotic-assisted major Pancreatic resection and reconstruction.
- Serum biomarker panels for the detection of pancreatic Cancer.
- Apoptosis to autophagy switch triggered by the MHC class III-encoded receptor for advanced glycation endproDucts (RAGE).
- HMGB1: a novel Beclin 1-binding protein active in autophagy.
- The redox protein HMGB1 regulates cell death and survival in Cancer treatment.
- Pancreatic lymphoepithelial cysts express CEA and can contain mucous cells: potential pitfalls in the preoperative diagnosis.
- Endogenous HMGB1 regulates autophagy.
- Adjuvant Stereotactic Body Radiotherapy for Resected Pancreatic AdenoCarcinoma with Close or Positive Margins.
- Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for coloRectal peritoneal carcinomatosis.
- EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic Cancer.
- In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusion.
- Ethyl pyruvate administration inhibits hepatic tumor growth.
- A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal Cancer.
- Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal Cancer.
- Loss of heterozygosity predicts poor survival after resection of pancreatic adenoCarcinoma.
- Array comparative genomic hybridization Analysis of solid pseudopapillary neoplasms of the pancreas.
- Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary Cancer center.
- Serum immunoglobulin G fraction 4 levels in pancreatic Cancer: elevations not associated with autoimmune pancreatitis.
- High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy.
- Arginine and immunity.
- Early detection and staging of adenoCarcinoma of the pancreas.
- Masquerader: high mobility group box-1 and Cancer.
- Cytolytic cells induce HMGB1 release from melanoma cell lines.
- High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.
- The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2.
- Pancreaticoduodenectomy in the presence of superior mesenteric venous Obstruction.
- Addicted to death: invasive Cancer and the immune response to unscheduled cell death.
- One hundred laparoscopic Adrenalectomies: a single surgeon's experience.
- Prediagnostic serum biomarkers as early detection tools for pancreatic Cancer in a large prospective cohort study.
- Minimally Invasive Approaches to Pancreatic Surgery.
Schools
University of Pittsburgh Main Campus
Johns Hopkins University School Med
Procedures Preformed
- Adrenalectomy
- Biliary Drainage
- Cholecystectomy with Robotic Assistance
- Colectomy
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Johns Hopkins University -
University of Pittsburgh School of Medicine
Hospital
-
UPMC Passavant -
UPMC Presbyterian Shadyside
Helpful Reviews
Similar Doctors
|
|
Dr. Fady K. Balaa, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen M. Erb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michelle L. Zuba, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly L. McCoy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Javier S. Pogacnik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul M. Willis, MD |
|
|
Dr. Argyro Bizaki, MD |
|
|
Dr. Richard A. Cheek III, MD |
|
|
Dr. John R. Klune, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roxana Fu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Klaus J. Walgenbach, MD |
|
|
Dr. Bhavin C. Shah, MD |